DSM-Firmenich stock holds steady as H1 2026 growth shifts toward Taste, Texture & Health

DSM-Firmenich stock (ISIN CH1216478797) is trading largely stable as of early September 2026, while the Swiss-based nutrition and fragrance group underlines its H1 2026 performance with a particular focus on growth in its Taste, Texture & Health segment and an ongoing share repurchase program as disclosed on September 1, 2026 via the Dutch regulator AFM.

H1 2026 results highlight shifting growth

According to an overview of sector financials for the first half of 2026 compiled by Food Ingredients First, DSM-Firmenich reported that sales in its Taste, Texture & Health division grew by 6% year on year on a like-for-like basis in Q2 2026, accelerating from 2% year-on-year growth in Q1 2026.

The same sector analysis notes that this acceleration in Q2 2026 was driven primarily by beverages, baking and dairy applications, as well as revenue synergies following the DSM and Firmenich combination, underlining that the company is gradually unlocking cross-selling effects across its portfolio during the first half of 2026.

Share buyback program continues into September 2026

In addition to operating trends, DSM-Firmenich is returning capital to shareholders through a share repurchase program documented in an inside information register of the Dutch Authority for the Financial Markets (AFM).

Per a disclosure published on September 1, 2026 in the AFM register of inside information, DSM-Firmenich AG reported weekly progress on its share repurchase program intended both to cover share-based plans and to reduce capital, confirming that the buyback activity is still ongoing as the company enters September 2026.

Taste, Texture & Health as a representative business

The Taste, Texture & Health division of DSM-Firmenich develops ingredients for beverages, baking, dairy and other food categories, and the H1 2026 data cited by Food Ingredients First indicates that like-for-like sales growth in this segment accelerated from 2% in Q1 2026 to 6% in Q2 2026, illustrating a four percentage point improvement in quarterly growth momentum within a single half-year period.

DSM-Firmenich stock and investor perspective

Based on sector and index overviews for European equities as of September 2, 2026, DSM-Firmenich stock is part of the broader Swiss and European large-cap universe, with investors watching both the ongoing H1 2026 growth in key segments such as Taste, Texture & Health and the capital allocation signal from the share repurchase program reported in the AFM register on September 1, 2026.